{"transactions":[{"id":713486,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-07-07T20:05:37.000Z","date":"2026-07-05","kind":"grant","planned":false,"acquired":true,"shares":25370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":25370,"derivative":{"exercise_price":14.8,"expiration_date":"2036-07-05","underlying":"Common Stock","underlying_shares":25370},"source":{"system":"sec-edgar","filing":"0001193805-26-000929","document":"e665632_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000929/e665632_4-jorg.xml","form_type":"4"}},{"id":723877,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-29T20:32:51.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":25370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested as of March 27, 2026."}],"balance_after":25370,"derivative":{"exercise_price":10.9,"expiration_date":"2036-03-27","underlying":"Common Stock","underlying_shares":25370},"source":{"system":"sec-edgar","filing":"0001193805-26-000888","document":"e665608_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000888/e665608_4-jorg.xml","form_type":"4"}},{"id":1117689,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-09T20:07:05.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":150000,"derivative":{"exercise_price":0.7729,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193805-25-000838","document":"e664607_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000838/e664607_4-jorg.xml","form_type":"4"}},{"id":1121104,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:07:04.000Z","date":"2025-06-05","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.76,"value":22800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 5, 2025 (at Euro 1.00 = U.S. dollar 1.1477)."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001193805-25-000800","document":"e664594_4-jorg.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000800/e664594_4-jorg.xml","form_type":"4"}},{"id":1121103,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:07:04.000Z","date":"2025-06-04","kind":"purchase","planned":false,"acquired":true,"shares":70000,"price":0.77,"value":53900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7661 to $0.7730. The Reporting Person (RP) undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchases were made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384)."}],"balance_after":170000,"source":{"system":"sec-edgar","filing":"0001193805-25-000800","document":"e664594_4-jorg.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000800/e664594_4-jorg.xml","form_type":"4"}},{"id":1481906,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-12T20:08:53.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":100000,"derivative":{"exercise_price":1.27,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-24-000788","document":"e663707_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000788/e663707_4-jorg.xml","form_type":"4"}},{"id":1591185,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:50:26.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":64959,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":64959,"derivative":{"exercise_price":1.72,"underlying":"Common Stock","underlying_shares":64959},"source":{"system":"sec-edgar","filing":"0001193805-24-000319","document":"e619333_4-joerg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000319/e619333_4-joerg.xml","form_type":"4"}},{"id":1591184,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:50:26.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":3.4,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-24-000319","document":"e619333_4-joerg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000319/e619333_4-joerg.xml","form_type":"4"}},{"id":1591183,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:50:26.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":14.77,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-24-000319","document":"e619333_4-joerg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000319/e619333_4-joerg.xml","form_type":"4"}},{"id":1591182,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:50:26.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":12.3,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000319","document":"e619333_4-joerg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000319/e619333_4-joerg.xml","form_type":"4"}},{"id":1591181,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-07T02:50:26.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":29959,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the \"Eligible Options\") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date."}],"balance_after":0,"derivative":{"exercise_price":13.63,"expiration_date":"2029-07-22","underlying":"Common Stock","underlying_shares":29959},"source":{"system":"sec-edgar","filing":"0001193805-24-000319","document":"e619333_4-joerg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380524000319/e619333_4-joerg.xml","form_type":"4"}},{"id":1841923,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-29T20:38:01.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":16000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001193805-23-000917","document":"e618743_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380523000917/e618743_4-jorg.xml","form_type":"4"}},{"id":2084955,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T21:06:28.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":47000,"price":1.256,"value":59032.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.22 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 14, 2022."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001193805-22-001729","document":"e618126_4-jorg.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522001729/e618126_4-jorg.xml","form_type":"4"}},{"id":2084954,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T21:06:28.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":35000,"price":1.246,"value":43610.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.23 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 13, 2022."}],"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001193805-22-001729","document":"e618126_4-jorg.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522001729/e618126_4-jorg.xml","form_type":"4"}},{"id":2104102,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-25T21:05:28.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":18000,"price":1.39,"value":25020.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001193805-22-001609","document":"e618059_4-jorg.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522001609/e618059_4-jorg.xml","form_type":"4"}},{"id":2227385,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-18T01:33:07.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":10000,"derivative":{"exercise_price":3.4,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-22-000970","document":"e621757_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380522000970/e621757_4-jorg.xml","form_type":"4"}},{"id":2669939,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-06-14T21:01:29.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":10000,"derivative":{"exercise_price":14.77,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-21-000865","document":"e620709_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380521000865/e620709_4-jorg.xml","form_type":"4"}},{"id":3088554,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-07-07T00:17:18.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":15000,"derivative":{"exercise_price":12.3,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-20-000797","document":"e619750_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380520000797/e619750_4-jorg.xml","form_type":"4"}},{"id":3456610,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31659,"kind":"person","name":"Neermann Joerg","position":1,"cik":"0001773900","reported_name":"Neermann Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-07-24T21:48:59.000Z","date":"2019-07-22","kind":"grant","acquired":true,"shares":29959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"9,986 of the options vest in monthly increments over a period of one year from the grant date, and 19,973 of the options vest in monthly increments over a period of three years from the grant date."}],"balance_after":29959,"derivative":{"exercise_price":13.63,"expiration_date":"2029-07-22","underlying":"Common Stock","underlying_shares":29959},"source":{"system":"sec-edgar","filing":"0001193805-19-000672","document":"e618566_4-jorg.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380519000672/e618566_4-jorg.xml","form_type":"4"}}]}